Christoph Harter

In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/tetherin in humans

Elina Erikson, Tarek Adam, Sarah Schmidt et al. · Proceedings of the National Academy of Sciences · 2011 · 89 citations · Full text

Life Sciences, Cell Biology, Immunology +12

Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients—a double-blind, randomised, prospective, controlled trial

Torben Ostendorf, Andrea Meinhold, Christoph Harter et al. · Supportive Care in Cancer · 2005 · 80 citations

Medicine, Clinical Pharmacy, Hematology +7

Intravenous Delivery of Autologous Mesenchymal Stem Cells Limits Infarct Size and Improves Left Ventricular Function in The Infarcted Porcine Heart

U. Krause, Christoph Harter, Anja Seckinger et al. · Stem Cells and Development · 2007 · 71 citations

Life Sciences, Biotechnology, Cardiology +15

Catheter‐related infection and thrombosis of the internal jugular vein in hematologic‐oncologic patients undergoing chemotherapy

Christoph Harter, Hans Salwender, Alfons Bach et al. · Cancer · 2001 · 67 citations

Medicine, Hematology, Oncology +14

Cytokine‐induced killer cells against autologous CLL: Direct cytotoxic effects and induction of immune accessory molecules by interferon‐γ

Martin Kornacker, Gerhard Moldenhauer, Markus Herbst et al. · International Journal of Cancer · 2006 · 65 citations · Full text

Life Sciences, Hematology, Immunology +17